Cambridge, UK · United Kingdom
Health · Biotechnology · DeepTech
Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the BlueYard Capital network.
Something looks off?
Open jobs at Biofidelity